Development of a high-speed, multiplexed sample-delivery instrument for LC-MS/MS bioanalysis.

BACKGROUND The number of new chemical entities and types of in vitro and in vivo samples that require bioanalysis in drug discovery is large and diverse. In addition, method development time is limited as data turnaround is the highest priority. These circumstances require that a well-defined set of bioanalysis options be available in short timeframes to triage samples for analysis. METHOD The Apricot Designs Dual Arm (ADDA) instrument is an LC-MS/MS sample delivery system that features a flexible hardware design coupled with software automation to enhance throughput in LC-MS/MS bioanalysis drug discovery. The instrument can perform high-throughput LC-MS/MS (8-10 s/sample) for screening and in vitro bioanalysis, as well as multiplexed LC for traditional gradient or isocratic LC approaches. The instrument control software is designed to integrate with DiscoveryQuant™ software (AB Sciex) and a global database of MS/MS conditions. CONCLUSION Development of the sample delivery platform and its application in high-throughput and gradient LC will be described.

[1]  Naidong Weng,et al.  Evaluation of a high-throughput online solid phase extraction-tandem mass spectrometry system for in vivo bioanalytical studies. , 2011, Analytical chemistry.

[2]  M. Cole,et al.  Desorption Ionization Techniques for Quantitative Analysis of Drug Molecules , 2008 .

[3]  R. Süssmuth,et al.  An integrated platform for fully automated high-throughput LC–MS/MS analysis of in vitro metabolic stability assay samples , 2010 .

[4]  Paul D. Leeson,et al.  The influence of the 'organizational factor' on compound quality in drug discovery , 2011, Nature Reviews Drug Discovery.

[5]  T. Covey,et al.  Characterization and performance of MALDI on a triple quadrupole mass spectrometer for analysis and quantification of small molecules. , 2005, Analytical chemistry.

[6]  Caroline A. Lee,et al.  Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds. , 2008, Journal of pharmacological and toxicological methods.

[7]  K. Youdim,et al.  An automated, high-throughput, 384 well Cytochrome P450 cocktail IC50 assay using a rapid resolution LC-MS/MS end-point. , 2008, Journal of pharmaceutical and biomedical analysis.

[8]  D. Kassel.  In Vitro ADME Profiling and Pharmacokinetic Screening in Drug Discovery , 2012 .

[9]  Jun Zhang,et al.  An integrated bioanalytical platform for supporting high-throughput serum protein binding screening. , 2010, Rapid communications in mass spectrometry : RCM.

[10]  Sean Ekins,et al.  Optimizing Higher Throughput Methods to Assess Drug-Drug Interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 In Vitro Using a Single Point IC50 , 2002, Journal of biomolecular screening.

[11]  L. Cohen,et al.  Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[12]  K. Youdim,et al.  A review of LC-MS techniques and high-throughput approaches used to investigate drug metabolism by cytochrome P450s. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[13]  D. Kassel,et al.  A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry. , 2010, Journal of chromatography. A.

[14]  David B Duignan,et al.  High throughput ADME screening: practical considerations, impact on the portfolio and enabler of in silico ADME models. , 2008, Current drug metabolism.

[15]  Hans-Joachim Böhm,et al.  A guide to drug discovery: Hit and lead generation: beyond high-throughput screening , 2003, Nature Reviews Drug Discovery.

[16]  Li Di,et al.  Drug-like property concepts in pharmaceutical design. , 2009, Current pharmaceutical design.

[17]  Bradley L Ackermann,et al.  Current applications of liquid chromatography/mass spectrometry in pharmaceutical discovery after a decade of innovation. , 2008, Annual review of analytical chemistry.

[18]  John Janiszewski,et al.  A centralized approach to tandem mass spectrometry method development for high-throughput ADME screening. , 2006, Rapid communications in mass spectrometry : RCM.

[19]  R. Süssmuth,et al.  Application of a Rapid and Integrated Analysis System (RIAS) as a High-Throughput Processing Tool for In Vitro ADME Samples by Liquid Chromatography/Tandem Mass Spectrometry , 2011, Journal of biomolecular screening.

[20]  J. Halladay,et al.  High-Throughput, 384-Well, LC-MS/MS CYP Inhibition Assay Using Automation, Cassette-Analysis Technique, and Streamlined Data Analysi. , 2011, Drug metabolism letters.

[21]  John S Janiszewski,et al.  Perspectives on bioanalytical mass spectrometry and automation in drug discovery. , 2008, Current drug metabolism.

[22]  T. L. Lloyd,et al.  High-speed gradient parallel liquid chromatography/tandem mass spectrometry with fully automated sample preparation for bioanalysis: 30 seconds per sample from plasma. , 2002, Rapid communications in mass spectrometry : RCM.

[23]  Wilson Z Shou,et al.  Recent development in high-throughput bioanalytical support for in vitro ADMET profiling , 2010, Expert opinion on drug metabolism & toxicology.

[24]  E. Duchoslav,et al.  A high-capacity LC/MS system for the bioanalysis of samples generated from plate-based metabolic screening. , 2001, Analytical chemistry.

[25]  R. Franklin,et al.  An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS. , 2011, Drug metabolism letters.